Petros Pharmaceuticals Inc (PTPI)
1.47
+0.02
(+1.38%)
USD |
NASDAQ |
Mar 28, 16:00
1.47
0.00 (0.00%)
After-Hours: 16:55
Petros Pharmaceuticals Total Assets (Quarterly): 38.91M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 38.91M |
June 30, 2023 | 28.73M |
March 31, 2023 | 30.57M |
December 31, 2022 | 32.42M |
September 30, 2022 | 37.70M |
June 30, 2022 | 51.05M |
Date | Value |
---|---|
March 31, 2022 | 55.86M |
December 31, 2021 | 67.39M |
September 30, 2021 | 52.04M |
June 30, 2021 | 56.67M |
March 31, 2021 | 66.15M |
December 31, 2020 | 69.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.73M
Minimum
Jun 2023
69.85M
Maximum
Dec 2020
48.95M
Average
51.54M
Median
Total Assets (Quarterly) Benchmarks
Acurx Pharmaceuticals Inc | 7.709M |
Assembly Biosciences Inc | 51.63M |
Oramed Pharmaceuticals Inc | 220.55M |
Cellectar Biosciences Inc | 21.55M |
Instil Bio Inc | 325.63M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 31.86M |
Shareholders Equity (Quarterly) | 7.057M |
Debt to Equity Ratio | 1.189 |
Current Ratio | 3.023 |
Net Debt Paydown Yield | 8.93% |